Revenue from Contracts with Customers - Disaggregation of Revenue (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2026 USD ($)	Sep. 30, 2025 USD ($)	Sep. 30, 2026 USD ($) segment item	Sep. 30, 2025 USD ($)
Disaggregation of Revenue [Line Items]
Number of operating segments \| segment			1
Number of product categories \| item			2
Revenue	$ 416,244	$ 384,157	$ 1,216,964	$ 1,121,970
Foundational
Disaggregation of Revenue [Line Items]
Revenue	275,735	260,906	812,175	763,670
Access
Disaggregation of Revenue [Line Items]
Revenue	157,922	151,508	470,832	438,028
OEM
Disaggregation of Revenue [Line Items]
Revenue	46,278	41,499	134,156	128,140
Procedural Solutions
Disaggregation of Revenue [Line Items]
Revenue	27,162	32,287	81,599	92,597
Vascular Intervention
Disaggregation of Revenue [Line Items]
Revenue	42,367	35,391	123,057	103,195
Other
Disaggregation of Revenue [Line Items]
Revenue	2,006	221	2,531	1,710
Therapeutic
Disaggregation of Revenue [Line Items]
Revenue	140,509	123,251	404,789	358,300
Cardiac Therapies
Disaggregation of Revenue [Line Items]
Revenue	27,547	25,530	83,461	69,019
Endoscopy
Disaggregation of Revenue [Line Items]
Revenue	23,428	17,631	68,767	52,582
OEM
Disaggregation of Revenue [Line Items]
Revenue	13,089	9,953	33,365	30,830
Oncology
Disaggregation of Revenue [Line Items]
Revenue	27,085	23,263	76,367	69,257
Renal Therapies
Disaggregation of Revenue [Line Items]
Revenue	13,550	13,808	37,775	40,014
Vascular Intervention
Disaggregation of Revenue [Line Items]
Revenue	35,810	33,066	105,054	96,598
United States
Disaggregation of Revenue [Line Items]
Revenue	255,946	230,597	734,513	671,243
International
Disaggregation of Revenue [Line Items]
Revenue	$ 160,298	$ 153,560	$ 482,451	$ 450,727